Learn more about the Comirnaty and Pfizer-BioNTech COVID-19 vaccine. The administration of a third dose in certain immunocompromised patients.The vaccine remains available under EUA, including for both of these: On August 23, 2021, the FDA approved the Pfizer-BioNTech COVID-19 vaccine, marketed as Comirnaty, for the prevention of COVID-19 disease in patients 16 years and older. On September 22, 2021, the FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech (PDF) COVID-19 vaccine to allow for use of a single booster dose for certain populations. If you're a person with Medicare, learn more about your Medicare coverage for COVID-19 vaccines, and find a COVID-19 vaccine near you. This toolkit is for health care providers.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |